June Webinar: Rivaroxaban or Fondaparinux for
Patients with Superficial-Vein Thrombosis
Tuesday, June 20, 12:00 Eastern
Superficial-vein thrombosis can lead to deep vein thrombosis and pulmonary embolism. In our June webinar, we will discuss the SURPRISE trial which compared efficacy outcomes in patients using rivaroxaban and fondaparinux. Our guest will be the lead investigator, Dr. Jan Beyer-Westendorf, MD, of the University Hospital "Carl Gustav Carus" in Dresden, Germany.
To read an abstract of the study in the Lancet Haematology, click here.
Our webinars are free and open to all medical professionals. Advance registration is required.